News & Media

Stay in the know
Research News

Clinical Trial Shows Promise in Treating Advanced Gastric Cancer

5 October 2024

A recent phase l trial evaluated the safety and efficacy of combining pressurised intraperitoneal aerosol chemotherapy-o...

Read More →
News

N2CR Members Named in Top 2% of Scientists Cited Worldwide

25 September 2024

Every year Stanford University publishes a list of highly cited scientists based on citation metrics from Scopus. The li...

Read More →
Research News

New Hope for Gastric Cancer Patients with Peritoneal Metastasis

16 September 2024

A breakthrough study, co-led by N2CR member A/Prof Raghav Sundar and includes Prof Jimmy So, A/Prof Yvonne Tay and Dr Yo...

Read More →
Research News

Potential New Approach to Boost Myeloma Treatment by Blocking Key Cancer Gene

6 September 2024

Multiple myeloma is a cancer of plasma cells, and its development and therapy resistance remain poorly understood. This ...

Read More →
Research News

Novel Drug Induces Colorectal Cancer Cell Death by Inhibiting Wnt Signaling

29 August 2024

This study co-led by N2CR member A/Prof Gautam Sethi, investigates the effects of CHL-C (an imidazopyridine-tethered cha...

Read More →
Research News

CD151 Overexpression: Prognosis and Therapy in EGFR-Negative NSCLC

22 August 2024

This study explores CD151’s (a protein linked to cancer progression) role in non-small cell lung cancer (NSCLC) pa...

Read More →
Research News

PGRN-EGFR Crosstalk Modulates ADAR1-Mediated Liver Immunity

30 July 2024

In this study, led by A/Prof Polly Chen, multi-omics approaches revealed that MDA5 loss in ADAR1-deficient livers does n...

Read More →
Research News

Next-Generation Sequencing in Metastatic Breast Cancer: A Game Changer for Asian Patients

11 July 2024

This study, led by N2CR members Dr Joline Lim and A/Prof David Tan, looks at the use of next-generation sequencing (NGS)...

Read More →
Research News

Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

1 July 2024

Cell cycle dysregulation, a key feature of cancer, leads to excessive cell division. CDK4 and CDK6 are essential for cel...

Read More →